Abstract

Hepatitis E virus (HEV) is the first cause of viral hepatitis in the world. While the water-borne HEV genotypes 1 and 2 are found in developing countries, HEV genotypes 3 and 4 are endemic in developed countries due to the existence of animal reservoirs, especially swine. An HEV infection produces many extra-hepatic manifestations in addition to liver symptoms, especially neurological disorders. The most common are neuralgic amyotrophy or Parsonage–Turner syndrome, Guillain–Barré syndrome, myelitis, and encephalitis. The pathophysiology of the neurological injuries due to HEV remains uncertain. The immune response to the virus probably plays a role, but direct virus neurotropism could also contribute to the pathophysiology. This review describes the main neurological manifestations and their possible pathogenic mechanisms.

Highlights

  • Infection: NeurologicalThe hepatitis E virus (HEV) is a leading cause of acute hepatitis worldwide, causing2 million infections and 70,000 deaths every year [1]

  • This study found that 11/464 (2.4%) of them were positive for anti-HEV IgM ± HEV RNA [43]

  • A replicon system based on the HEV3 Kernow-C1 p6 strain, in which ORF2 is replaced by the Gaussia luciferase and is secreted following RNA replication [85], was used to study the capacity of human neural cell lines to support HEV replication

Read more

Summary

Introduction

The hepatitis E virus (HEV) is a leading cause of acute hepatitis worldwide, causing. ORF1 encodes a non-structural protein with enzymatic domains, including a methyltransferase, a papain-like cysteine protease, a helicase, and a RNA-dependent RNA polymerase. There have been recent reports of nine cases of patients infected with Orthohepevirus C HEV [11,12,13], which is surprising because this virus differs genetically from other human pathogenic strains [14]. Extra-hepatic, especially neurological, manifestations have frequently been described in both acutely and chronically HEV infected patients. This review describes these clinical manifestations and discusses the pathogenic mechanisms that might be involved

Clinical Manifestations
Neuralgic Amyotrophy
Guillain–Barré Syndrome
Other Neurological Manifestations
Pathophysiology
In Vivo Evidence of the CNS Tropism of HEV
In-Vitro Evidence of the CNS Tropism of HEV
Diagnosis and Treatment
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call